Acerus Pharmaceuticals - Growing Canadian specialty pharma business
Acerus commercialises selected specialty pharmaceutical products in Canada and relies on partners for the US and other markets. Natesto sales growth in North America, along with other new products to be launched over the next 24 months, could potentially enable Acerus to deliver positive ongoing cash flows and EBITDA by the end of this period.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.